Molecular imaging approaches to facilitate bacteria-mediated cancer therapy

Adv Drug Deliv Rev. 2022 Aug:187:114366. doi: 10.1016/j.addr.2022.114366. Epub 2022 May 30.

Abstract

Bacteria-mediated cancer therapy is a potential therapeutic strategy for cancer that has unique properties, including broad tumor-targeting ability, various administration routes, the flexibility of delivery, and facilitating the host's immune responses. The molecular imaging of bacteria-mediated cancer therapy allows the therapeutically injected bacteria to be visualized and confirms the accurate delivery of the therapeutic bacteria to the target lesion. Several hurdles make bacteria-specific imaging challenging, including the need to discriminate therapeutic bacterial infection from inflammation or other pathologic lesions. To realize the full potential of bacteria-specific imaging, it is necessary to develop bacteria-specific targets that can be associated with an imaging assay. This review describes the current status of bacterial imaging techniques together with the advantages and disadvantages of several imaging modalities. Also, we describe potential targets for bacterial-specific imaging and related applications.

Keywords: Bacteria-medicated cancer therapy; Molecular imaging; Optical imaging; PET; Photoacoustic imaging; SPECT; Target.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteria
  • Bacterial Infections* / diagnostic imaging
  • Bacterial Infections* / drug therapy
  • Humans
  • Molecular Imaging
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / therapy